Acute and chronic effects of 3,4-dimethoxyphenylacetamide on plasma glucose and cholesterol in rats.
D000081:Acetamides / Q000008:administration & dosage / Q000494:pharmacology*; D000284:Administration, Oral; D000818:Animals; D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects; D001786:Blood Glucose; D001835:Body Weight / Q000187:drug effects; D002396:Catechols / Q000008:administration & dosage / Q000494:pharmacology*; D002784:Cholesterol / Q000097:blood*; D004305:Dose-Response Relationship, Drug; D007274:Injections, Intraperitoneal; D008297:Male; D008738:Methyl Ethers / Q000008:administration & dosage / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors
D000081:Acetamides; D000924:Anticholesteremic Agents; D001786:Blood Glucose; D002396:Catechols; D008738:Methyl Ethers; C001879:3,4-dimethoxyphenylacetamide; D002784:Cholesterol